Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2010
04/15/2010US20100093866 Pharmaceutical Formulations
04/15/2010US20100093865 Sulphur-linked compounds for treating ophthalmic diseases and disorders
04/15/2010US20100093864 Anti-infective thiourea compounds
04/15/2010US20100093863 Use of citrulline for preventing an increase in protein carbonylation and for treating diseases resulting therefrom
04/15/2010US20100093862 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors.
04/15/2010US20100093861 Treatment of insulin resistance or diseases associated with insulin resistance
04/15/2010US20100093860 Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives
04/15/2010US20100093859 Compositions and Methods For Enhancing Neurological Development
04/15/2010US20100093858 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops
04/15/2010US20100093857 Amido-amine polymer compositions
04/15/2010US20100093856 Omega-3 diglyceride emulsions
04/15/2010US20100093855 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
04/15/2010US20100093854 Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester
04/15/2010US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
04/15/2010US20100093852 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof
04/15/2010US20100093851 Silver polyamide composite
04/15/2010US20100093850 Composition containing metal-acidic amino acid chelate accelerating absorption of metal
04/15/2010US20100093849 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer
04/15/2010US20100093848 Propargylated aminoindans, processes for preparation, and uses thereof
04/15/2010US20100093847 Anti-obesity active agent and anti-obesity method
04/15/2010US20100093845 Composition and method for treating dry eye syndrome
04/15/2010US20100093843 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints
04/15/2010US20100093842 Laulimalide Analogs and Uses Thereof
04/15/2010US20100093841 Cell culture system of a hepatitis c genotype 3a and 2a chimera
04/15/2010US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia
04/15/2010US20100093838 Regulation of angiogenesis with zinc finger proteins
04/15/2010US20100093837 Microrna molecules
04/15/2010US20100093836 Compounds and methods for modulating protein expression
04/15/2010US20100093835 RNA INTERFERENCE MEDIATED INHIBITION OF MYC AND/OR MYB GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
04/15/2010US20100093833 Methods for Inducing Differentiation of Undifferentiated Mammalian Cells Into Osteoblasts
04/15/2010US20100093832 Modulation of insulin like growth factor i receptor expression in cancer
04/15/2010US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
04/15/2010US20100093830 Modulation of MLCK-L Expression and Uses Thereof
04/15/2010US20100093829 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures
04/15/2010US20100093828 Compounds for the treatment of proliferative disorders
04/15/2010US20100093827 Method for topical treatment of tar-responsive dermatological disorders
04/15/2010US20100093826 Atropisomer of pyrrole derivative
04/15/2010US20100093825 Bicycloester derivative
04/15/2010US20100093824 Methods of treating viral infection
04/15/2010US20100093823 Steroidal compounds as melanogenesis modifiers and uses thereof
04/15/2010US20100093822 Process for the Sulfinylation of a Pyrazole Derivative
04/15/2010US20100093821 3-Amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases
04/15/2010US20100093820 Crystalline pyrazoles
04/15/2010US20100093819 Phenylpropionic acid derivative and use thereof
04/15/2010US20100093818 Benzimidazole derivatives
04/15/2010US20100093817 Compounds
04/15/2010US20100093816 [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-ylmethyl]-dimethyl-ammonium napadisylate for treating chronic obstructive pulmonary disease
04/15/2010US20100093814 Novel compounds as cannabinoid receptor ligands and uses thereof
04/15/2010US20100093813 Salts 668
04/15/2010US20100093812 Desferrithiocin polyether analogues
04/15/2010US20100093811 Hiv protease inhibitors
04/15/2010US20100093810 Pharmaceutical Compositions for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis
04/15/2010US20100093809 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
04/15/2010US20100093808 Salt and polymorph of a dpp-iv inhibitor
04/15/2010US20100093807 Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions
04/15/2010US20100093806 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
04/15/2010US20100093805 Method of treating amblyopia
04/15/2010US20100093804 novel crystalline form of lansoprazole
04/15/2010US20100093803 Substituted dipyridyl-dihydropyrazolones and use thereof
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093801 Piperidine compounds, pharmaceutical composition comprising the same and its use
04/15/2010US20100093800 Apparatus, method and drug products for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
04/15/2010US20100093799 For reducing levels of tumor necrosis factor alpha in mammals; 3-(3-Nitrophthalimido)-3-methylpiperidine-2,6-dione; 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline
04/15/2010US20100093798 Cyclic modulators of chemokine receptor activity
04/15/2010US20100093797 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
04/15/2010US20100093796 Methods and devices for providing prolonged drug therapy
04/15/2010US20100093795 Piperidine Derivative Used for Treating Chemokine Receptor 5 Mediated Diseases
04/15/2010US20100093794 Use of a Compound in Obtaining Cytoskeleton Blockage and Cell Elongation
04/15/2010US20100093793 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
04/15/2010US20100093792 Crystalline forms of a potent hcv inhibitor
04/15/2010US20100093791 Therapeutic Compositions
04/15/2010US20100093790 Isoquinoline compounds
04/15/2010US20100093789 Sulfonamide compound
04/15/2010US20100093788 Heterocyclic benzimidazoles as trpm8 modulators
04/15/2010US20100093787 Treatment of impaired respiratory function with gaboxadol
04/15/2010US20100093786 Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
04/15/2010US20100093785 Diamine derivatives
04/15/2010US20100093784 Novel heterocyclic nitrogenous compounds, their preparation and their use as antibacterial medicaments
04/15/2010US20100093783 Composition for treatment of common cold
04/15/2010US20100093782 Pyrazolonaphthyridine derivatives
04/15/2010US20100093781 Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitors
04/15/2010US20100093780 Insulin resistance improving agent
04/15/2010US20100093779 Hcv ns3 protease inhibitors
04/15/2010US20100093778 Sustained release parenteral formulations of buprenorphine
04/15/2010US20100093777 Spiro-ring compound
04/15/2010US20100093776 Organic Compounds and Their Uses
04/15/2010US20100093775 Compounds and methods for the treatment or prevention of flavivirus infections
04/15/2010US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same
04/15/2010US20100093773 Methods of treating cancer
04/15/2010US20100093772 Quinazoline derivatives and their use in the treatment of thrombocythemia
04/15/2010US20100093771 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the same
04/15/2010US20100093770 Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
04/15/2010US20100093769 Compounds
04/15/2010US20100093768 Agents for Reversing Epigenetic Silencing of Genes
04/15/2010US20100093767 Mitotic Kinase Inhibitors
04/15/2010US20100093766 Novel compounds
04/15/2010US20100093765 Novel compounds
04/15/2010US20100093764 AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093763 PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093762 Methods for treating or preventing symptoms of hormonal variations
1 ... 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 ... 7860